Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.
Chamberlain
Marc C
MC
Chowdhary
Sajeel
S
D000998:Antiviral Agents / Q000627:therapeutic use; D001921:Brain / Q000276:immunology / Q000503:physiopathology / Q000821:virology; D003221:Confusion / Q000276:immunology / Q000503:physiopathology / Q000821:virology; D004279:DNA, Viral / Q000097:blood / Q000134:cerebrospinal fluid; D003937:Diagnosis, Differential; D005260:Female; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000276:immunology; D015654:Herpesvirus 6, Human / Q000235:genetics / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D020363:Limbic Encephalitis / Q000276:immunology* / Q000503:physiopathology / Q000821:virology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D008875:Middle Aged; D011237:Predictive Value of Tests; D019349:Roseolovirus Infections / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D016896:Treatment Outcome
D000998:Antiviral Agents; D004279:DNA, Viral; D007166:Immunosuppressive Agents; D017245:Foscarnet; D015774:Ganciclovir